Cases 11 - 16 of 16
Namenda Direct Purchaser Antitrust Litigation et al v. Forest Laboratories, LLC et al
as 1:2017mc00314
Petitioner:
Lupin Pharmaceuticals, Inc.
Respondent:
Forest Laboratories LLC , Forest Laboratories Inc. , Forest Laboratories Holdings Ltd. and others
Cause Of Action: M 08-85 Motion to Quash
Namenda Direct Purchaser Antitrust Litigation et al
as 1:2017mc00274
Movant:
Direct Purchaser Class Plaintiffs
Respondent:
Lupin Pharmaceuticals, Inc.
Cause Of Action: M 08-85 Motion to Compel
Kowa Company, Ltd. et al v. Lupin Limited et al
as 1:2015cv03935
Plaintiff:
Kowa Company, Ltd. , Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd.
Defendant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Counter_claimant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Counter_defendant:
Kowa Company, Ltd. , Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd.
Cause Of Action: 35 U.S.C. § 271
Teva Women's Health et al v. Lupin Limited
as 1:2014cv04055
Plaintiff:
Teva Women's Health and Teva Branded Pharmaceutical Products R & D, Inc.
Defendant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 145
Camp v. Lupin Pharmaceuticals Inc
as 3:2010cv01403
Plaintiff:
Doreen Camp
Defendant:
Lupin Pharmaceuticals, Inc.
Cause Of Action: 29 U.S.C. § 201
Bayer Schering Pharma AG et al v. Lupin Ltd. et al
as 1:2010cv05423
Plaintiff:
Bayer Schering Pharma AG and Bayer Healthcare Pharmaceuticals Inc.
Defendant:
Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
